Shivdasani Ramesh A, Schulze Harald
Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.
Curr Protoc Immunol. 2005 Jul;Chapter 22:Unit 22F.6. doi: 10.1002/0471142735.im22f06s67.
Megakaryocytes (MKs) are the source of circulating platelets and are readily recognized by their large size and distinctive morphology. Their poor representation in hematopoietic tissues often requires considerable ex vivo expansion to generate cells for biochemical and cell biological studies. These experimental protocols describe the assessment of megakaryocytic potential within hematopoietic precursor cells in the bone marrow by colony-forming assays and expansion and enrichment of MKs from cultured fetal liver or spleen or bone marrow cells. Although these MKs are not synchronized in their maturation, they can be enriched over an albumin step-gradient and one-third to one-half of recovered cells will typically elaborate proplatelets, the immediate precursors of blood platelets. Both protocols require recombinant thrombopoietin (TPO) as a growth factor. Support Protocols describe methods for preparing fetal liver cells, identifying mature rodent MKs by staining for acetylcholinesterase activity, and staining (May-Grünwald-Giemsa) mixed populations on cytocentrifuged blood cell preparations.
巨核细胞(MKs)是循环血小板的来源,其大尺寸和独特形态易于识别。它们在造血组织中的数量较少,通常需要大量的体外扩增才能产生用于生化和细胞生物学研究的细胞。这些实验方案描述了通过集落形成试验评估骨髓造血前体细胞中的巨核细胞潜能,以及从培养的胎肝、脾脏或骨髓细胞中扩增和富集巨核细胞。尽管这些巨核细胞的成熟不同步,但它们可以通过白蛋白阶梯梯度进行富集,回收细胞的三分之一到二分之一通常会形成前血小板,即血小板的直接前体。这两个方案都需要重组血小板生成素(TPO)作为生长因子。支持方案描述了制备胎肝细胞、通过乙酰胆碱酯酶活性染色鉴定成熟啮齿动物巨核细胞以及对细胞离心血液细胞制备物上的混合群体进行染色(May-Grünwald-Giemsa)的方法。